These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37799074)

  • 1. Identification of key immune cell-related genes involved in tumorigenesis and prognosis of cervical squamous cell carcinoma.
    Yan C; Ma Y; Li J; Chen X; Ma J
    Hum Vaccin Immunother; 2023 Aug; 19(2):2254239. PubMed ID: 37799074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cervical squamous cell carcinoma feature genes and construction of a prognostic model based on immune-related features.
    He C; Ren L; Yuan M; Liu M; Liu K; Qian X; Lu J
    BMC Womens Health; 2022 Sep; 22(1):365. PubMed ID: 36057587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Molecule PLA2G2D Is a Potential Prognostic Biomarker Correlating With Immune Cell Infiltration and the Expression of Immune Checkpoint Genes in Cervical Squamous Cell Carcinoma.
    Liu H; Xu R; Gao C; Zhu T; Liu L; Yang Y; Zeng H; Huang Y; Wang H
    Front Oncol; 2021; 11():755668. PubMed ID: 34733790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic genes in the tumor microenvironment in cervical squamous cell carcinoma.
    Pan XB; Lu Y; Huang JL; Long Y; Yao DS
    Aging (Albany NY); 2019 Nov; 11(22):10154-10166. PubMed ID: 31740624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma.
    Zhu J; Zhao R; Xu W; Ma J; Ning X; Ma R; Meng F
    Biosci Trends; 2020 Sep; 14(4):279-284. PubMed ID: 32536673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma.
    Liu B; Xu Y; Hu B; Song X; Lin S; Wang J; Wang L; Chu T; Peng T; Xu M; Ding W; Cao C; Wu P; Li L
    Aging (Albany NY); 2024 Jan; 16(1):568-592. PubMed ID: 38206304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
    Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
    BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
    Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential biomarkers for the prognosis and treatment of HCC immunotherapy.
    Li H; He Q; Zhou GM; Wang WJ; Shi PP; Wang ZH
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2027-2046. PubMed ID: 36930502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acylglycerol kinase is over-expressed in early-stage cervical squamous cell cancer and predicts poor prognosis.
    Sun F; Xiong Y; Zhou XH; Li Q; Xiao L; Long P; Li LJ; Cai MY; Wei YX; Ma YL; Yu YH
    Tumour Biol; 2016 May; 37(5):6729-36. PubMed ID: 26662108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y; Liu H; Fu H; Ding GS; Teng F
    Front Immunol; 2022; 13():974377. PubMed ID: 36458010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA NEF inhibits migration and invasion of HPV-negative cervical squamous cell carcinoma by inhibiting TGF-β pathway.
    Ju W; Luo X; Zhang N
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
    Lin W; Feng M; Chen G; Zhou Z; Li J; Ye Y
    Oncol Rep; 2017 Mar; 37(3):1477-1486. PubMed ID: 28098890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
    Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
    Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
    [No Abstract]   [Full Text] [Related]  

  • 16. RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation.
    Zhang S; Wang H; Liu J; Tao T; Zeng Z; Wang M
    J Transl Med; 2022 Jul; 20(1):334. PubMed ID: 35879796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple datasets to explore the tumor microenvironment of cutaneous squamous cell carcinoma.
    Xing J; Chen M; Han Y
    Math Biosci Eng; 2022 Apr; 19(6):5905-5924. PubMed ID: 35603384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
    Yu L; Gao Z; Li Z; Liu P; Gao Y; Liang G
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14673-14689. PubMed ID: 37584713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
    Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
    Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma.
    Ou Z; Lin S; Qiu J; Ding W; Ren P; Chen D; Wang J; Tong Y; Wu D; Chen A; Deng Y; Cheng M; Peng T; Lu H; Yang H; Wang J; Jin X; Ma D; Xu X; Wang Y; Li J; Wu P
    Adv Sci (Weinh); 2022 Oct; 9(29):e2203040. PubMed ID: 35986392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.